Skip to content

Time-Efficient Inspiratory Muscle Strength Training for Reducing Sympathetic Activity and Improving Sleep in Midlife Women

Time-Efficient Inspiratory Muscle Strength Training for Reducing Sympathetic Activity and Improving Sleep in Midlife Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06743269
Enrollment
30
Registered
2024-12-19
Start date
2025-03-27
Completion date
2027-01-01
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure Regulation, Hot Flashes, Menopause

Keywords

menopause, blood pressure, inspiratory training, hot flashes

Brief summary

The purpose of this research is to understand how training the muscles used for breathing (inhalation) affects menopausal hot flashes, sympathetic nerve activity and sleep.

Interventions

Performs inspiratory maneuvers at 55% maximal inspiratory pressure (PIMAX) during week 1, 65% PIMAX during week 2, and 75% PIMAX during weeks 3-6.

BEHAVIORALLow-Resistance Inspiratory Muscle Strength Training

Performs inspiratory maneuvers at 15% maximal inspiratory pressure (PIMAX) for all 6 weeks.

DEVICEPOWERbreathe K3 device

Inspiratory muscle training device

Sponsors

Mayo Clinic
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Females aged 45-60 with hot flashes. * Participants will be recruited from Rochester, MN and surrounding areas. * Non-smokers. * BMI \< 40kg/m\^2. * No history of cardiovascular disease, except for hypertension.

Exclusion criteria

* Detailed medical and social histories will be collected. To allow for ecological validity, participants will not be excluded for use of menopausal hormone therapy or medications affecting cardiovascular function so long as they have been on a consistent regimen for ≥3 months and during the study period. This approach to medications is consistent with recent work in this area. * Participants will be screened for contraindications to inspiratory muscle strength training including, a history of spontaneous pneumothorax, collapsed lung that has not healed fully, a perforated eardrum that has not healed fully, and/or any other condition of the eardrum. * Additional

Design outcomes

Primary

MeasureTime frameDescription
Change in blood pressureBaseline, 6 weeksMeasured in millimeters of mercury (mm Hg)
Change in Muscle Sympathetic Nerve Activity (MSNA) burst frequencyBaseline, 6 weeksMeasured by microneurography reported in burst per minute
Change in Muscle Sympathetic Nerve Activity (MSNA) burst incidenceBaseline, 6 weeksNumber of bursts recorded via microneurography

Secondary

MeasureTime frameDescription
Change in Hot Flash FrequencyBaseline, 6 weeksNumber of hot flashes indicated through self-reporting
Chang in sleep durationBaseline, 6 weeksMeasured by actigraphy data defined as recorded number of minutes in sleep
Change in wake after sleep onsetBaseline, 6 weeksMeasured by actigraphy data defined as number of minutes from sleep onset to waking
Change in Pittsburgh Sleep Quality IndexBaseline, 6 weeksThe Pittsburgh Sleep Quality Index measures the severity of sleep disturbances. Possible scores range from 0 to 21 with higher scores indicating a worse outcome/more severe symptoms of sleep disturbance.

Countries

United States

Contacts

CONTACTPamela Engrav
engrav.pamela@mayo.edu(507) 255-6938
CONTACTNancy Meyer
meyer.nancy2@mayo.edu507-255-0913
PRINCIPAL_INVESTIGATORSarah Baker, PhD

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026